Intel Corp the world's biggest computer chip maker has won clearance from the U.S. Food and Drug Administration to sell a personal in-home health monitoring system for patients with chronic conditions.

The system, called Health Guide, combines an in-home patient device as well as online access that enable healthcare professionals to monitor patients and remotely manage care.
It incorporates interactive tools for personalized care management and integrates vital sign collection, patient reminders, multimedia educational content and feedback and communications tools such as video conferencing and e-mail.  The Health Guide system can connect to specific models of wired and wireless medical devices, including blood pressure monitors, glucose meters, pulse oximeters, peak flow meters and weight scales. It also stores and displays the collected information on a touch screen and sends to a secure host server, where healthcare professionals can review the information.
Intel said it expects the system to be commercially available from healthcare providers in the United States and the United Kingdom.